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Introduction
Non-steroidal anti-inflammatory drugs (NSAID) are used 
worldwide for the treatment of inflammation, pain and fever, 
as well as for cardiovascular protection. However, they often 
produce significant side-effects, which include gastric ulcer, 
renal damage, bronchospasm and cardiac abnormalities, 
thus limiting their use (Burke et al., 2006). Drugs of natural 
origin are an important source for the treatment of many 
diseases worldwide (Pandima Devi et al., 2003). The research 
and analysis of plants employed as pain-relievers and anti-
inflammatory agents in traditional ethnomedicine is one of the 
productive and logical strategies in the search for new drugs 
(Elisabetsky et al., 1995; Vongtau et al., 2004).
Alafia barteri Oliv., Apocynaceae, is a climbing shrub distributed 
widely in the tropics. It is valued for its efficacy in the traditional 
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A B S T R A C T
This study analyzes the antinociceptive and anti-inflammatory properties of ethanolic leaf 
extract of Alafia barteri Oliv., Apocynaceae, based on its medicinal use in the treatment of 
toothaches, inflammation and fevers. The antinociceptive effect was assessed in mice using 
acetic acid-induced writhing, tail clip, tail immersion and formalin assays. Anti-inflammatory 
activity was evaluated on carrageenan-induced paw oedema in rats, and xylene-induced 
ear oedema in mice. In acetic acid-induced writhing test, the extract at different doses (50, 
100 and 200 mg/kg, p.o.) significantly (p < 0.05) and dose-dependently reduced pain by 35.04, 
56.49 and 84.25%, respectively. The extract also significantly inhibited both the early and late 
phases of formalin-induced nociception in mice. In the tail immersion test, the extract caused 
a significant inhibition of pain (34.43% inhibition, after 90 min) at a dose of 200 mg/kg, while 
the effect of the extract in the tail clip test was only significant at the 100 mg/kg dose. A. barteri 
caused a significant inhibition of paw oedema development in the carrageenan and xylene-
induced oedema tests. There was no mortality recorded following treatment with the extract 
(5 g/kg, p.o.). The results support the traditional use of A. barteri in the treatment of various 
diseases associated with pain and inflammation.
© 2014 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. All rights reserved.
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medicine system in Nigeria and other African countries, as an 
anti-inflammatory and fever remedy. The infusion of the leaves 
and twining stem are used for the treatment of inflammation 
and fever (Burkill, 1985; Iwu, 1993). The decoction of root and 
leaves of the plant is also taken internally or applied externally 
to treat rheumatic pain, toothache and eye infections (Odugbemi, 
2008). The extracts of the leaves were found to have antibacterial 
and antifungal activities (Adekunle and Okoli, 2002; Hamid and 
Aiyelaagbe, 2011). The aqueous leaf extract was reported to display 
potent antiplasmodial activity (Lasisi et al., 2012). Aside these 
reports, and to the best of our knowledge, no other pharmacological 
effects of this plant related to its traditional use for antinociceptive 
and anti-inflammatory activities have been reported. Therefore, this 
study aimed to evaluate the antinociceptive and anti-inflammatory 
properties of the ethanolic extract of Alafia barteri leaves.
Materials and methods
Plant material
The leaves of Alafia barteri Oliv., Apocynaceae, were collected 
from Olokemeji forest, Ibadan (7°25’ N, 3°31’E), Nigeria, in 
January, 2012. The plant sample was authenticated by Mr T. 
K. Odewo of the herbarium unit of  the Department of Botany, 
University of Lagos, and a voucher specimen (LUH 2880) was 
deposited in the same unit.
Preparation of the plant extract
The leaves were air-dried and coarsely powdered using Christy 
and Norriis 8’ Lab Milling Machine (serial No. 50158). The powdered 
plant sample (310 g) was extracted with 96% ethanol (1.8 l) for 24 
h, at room temperature with constant stirring. This process was 
repeated twice for complete extraction. The extract was filtered 
and the filtrate was concentrated at 45°C on a regulated water bath 
(Julabo TW20GB, USA Inc.). The percentage yield was 2.8% (w/w). 
Spectroscopic methods for quantitative determination of 
phenolic compounds
Total phenol concentration in the ethanolic extract from leaves 
of A. barteri was determined spectrophotometrically, according 
to Folin-Ciocalteu colorimetric method (Menichini et al., 
2009) and expressed as gallic acid equivalents (mg/g) of dried 
extract (R² = 0.959). Total flavonoid content was measured 
by the aluminium chloride colorimetric assay (Rajasekaran 
et al., 2012) and expressed as quercetin equivalents (mg/g) 
of dried extract (R² = 0.961). Proanthocyanidin content was 
determined by the vanillin-HCl assay as described by Sun et 
al. (1998). Catechin was used as the standard (R² = 0.958) for 
the calibration curve, and the result was expressed as catechin 
equivalents (mg/g) of dried extract. 
Experimental animals
Swiss albino mice (17-25 g) and Wistar rats (150-200 g) were 
housed in clean plastic cages and maintained under standard 
laboratory conditions (temperature 24-28°C and 12:12 light/dark 
cycles). They were fed with commercial rat food (Livestock Feed 
PLC, Ikeja, Lagos, Nigeria) and water ad libitum. The procedures 
adopted in this study were in accordance with Guidelines for 
Care and Use of Laboratory Animals in Biomedical Research 
of the National Institutes of Health of the United States (NIH, 
1985), and approved by the Experimentation Ethics Committee 
on Animal Use of the College of Medicine, University of Lagos, 
Lagos, Nigeria (CM/COM/08/VOL.XXV). 
Acute toxicity
An acute toxicity assay was performed in accordance to OECD 
test guidelines 423 (limit test) and as reported by Ong et al. 
(2011). A single oral dose of A. barteri extract (5 g/kg) was 
administered to a group of seven fasting male mice, while 
the control group received vehicle (1% Tween 80, 10 ml/kg, 
p.o.). The animals were observed continuously for the first 4 
h and then periodically up to 24 h for toxic symptoms and 
mortality. The mice were further observed for seven days for 
manifestations of delayed toxicity. 
Assessment of antinociceptive effect of the extract
Acetic acid-induced writhing test
The antinociceptive effect was evaluated in mice by acetic 
acid-induced writhing test (Koster et al., 1959; Singh and 
Majumdar, 1995). Animals were randomly selected and divided 
into five groups of six animals each. Group I served as the 
control and received 1% Tween 80 (10 ml/kg, p.o.), groups II, 
III and IV received plant extract (50, 100 and 200 mg/kg, p.o., 
respectively) while group V, which served as positive control, 
received acetylsalicylic acid (ASA) (100 mg/kg, p.o.). One hour 
after the administration of the plant extract or standard drug, 
the animals received acetic acid (0.6%, 10 ml/kg, i.p.). The 
number of writhes (abdominal contractions and stretches) 
was counted for 30 min after the administration of acetic acid. 
The results were evaluated by calculating the mean number of 
writhes per group and antinociceptive activity was expressed 
as percentage inhibition of abdominal writhes.
Tail immersion test
The tail immersion test was performed according to the method 
of Ben-Bassat et al. (1959), as reported by Cha et al. (2011) with 
minor modifications. The mouse was gently handled and two-
thirds of its tail was immersed in a beaker containing water at a 
temperature of 55 ± 0.5°C. Each animal served as its own control. 
The reaction time, i.e. the amount of time it took the animal to 
withdraw its tail, was recorded with a stopwatch at 0, 30, 60, 
90 and 120 min after the administration of the extract (50, 100 
and 200 mg/kg, p.o.), vehicle (10 ml/kg, p.o.) or morphine (10 mg/
kg, s.c). To avoid tissue injury, the cut-off time was set at 20 s.
Tail clip test
Mice were screened by applying a metal artery clip to the 
base of the tail to induce pain. The animals that did not 
attempt to dislodge the clip within 10 s were not used for 
the experiment. The selected mice were divided into five 
groups of six mice each. The extract (50, 100 and 200 mg/kg, 
p.o.), morphine (10 mg/kg, s.c.) or 1% Tween 80 (vehicle, p.o.) 
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were administered to different groups of prescreened mice. 
The reaction time of each mouse was then determined 60 
minutes post-treatment for oral administration and 30 min 
post-treatment for subcutaneous administration (Bianchi and 
Franceschini, 1954; Ishola et al., 2011). A post-treatment cut-
off time of 30 s was used. The mean value was evaluated 
and percentage inhibition calculated as follows: % Inhibition 
= (post-treatment latency − pre-treatment latency)/(cut-off 
time − pre-treatment latency) ×100.
Formalin-induced pain test
The formalin test was carried out according to the method of 
Hunskaar and Hole (1987) as reported by Young et al. (2005) 
with some modifications. Twenty micro-liter of 1% formalin 
was injected into the right hind paw of mice, 60 min after 
administration of the extract (50, 100 and 200 mg/kg, p.o.) and 
Tween 80 (1%), and 30 min after morphine administration (10 
mg/kg, s.c.). Animals were placed individually in transparent 
cages and observed for 30 min after the injection of formalin, 
and the amount of time (in seconds) spent licking and biting the 
injected hind paw was recorded as an indicator of nociceptive 
behavior. The initial nociceptive scores normally peaked at 
0-5 min (early phase) and 15-30 min (late phase) after formalin 
injection, representing the neurogenic and inflammatory pain 
responses, respectively.
Assessment of anti-inflammatory effect of the extract
Carrageenan-induced paw oedema in rats
The anti-inflammatory activity of the extract was evaluated 
according to the method of Winter et al. (1962), and as reported 
by Ibrahim et al. (2012) with slight modifications. Five groups 
of six rats each were treated with the extract (50, 100 and 200 
mg/kg, p.o.), indomethacin (10 mg/kg, p.o.) or 1% Tween 80 (10 
ml/kg, p.o.). One hour after the administration of the various 
agents, edema was induced by carrageenan injection (0.1 ml, 
1%, w/v in saline) into the subplantar tissue of the right hind 
paw. The linear paw circumference (cm) was measured using 
the cotton thread method (Bamgbose and Noamesi, 1981). 
Measurements were made immediately before injection of 
the phlogistic agents and afterwards at 1 h intervals, for 5 h.
Xylene-induced ear edema in mice 
The xylene-induced ear oedema test was performed as 
previously described by Tang et al. (1984). Briefly, each 
mouse was given a single dose of the extract (50-200 mg/kg), 
dexamethasone (1 mg/kg) or vehicle 1 h before induction of 
ear oedema by topical application of 0.02 ml xylene on the 
inner and outer surfaces of the right ear. The left ear was 
used as a control. Mice were sacrificed by cervical dislocation 
1 h after xylene application. Circular sections were excised 
and weighed. The extent of ear oedema was evaluated by the 
weight difference between the right and the left ear sections 
of the same animal.
Statistical analysis 
The data are represented as the mean ± SEM. Statistically 
significant differences between the treatments were tested by 
One-way ANOVA. Differences were considered significant at p 
< 0.05. All statistical analysis was performed using GraphPad 
Prism 5.0 for Windows (GraphPad Software, San Diego, 
California, USA).
Results
Acute toxicity
A single oral administration of the extract (5 g/kg) did not 
produce any sign of toxicity and no mortality occurred within 
24 h after administration and after seven days observation. 
Antinociceptive activity
Acetic acid-induced writhing in rats
The extract (50, 100 and 200 mg/kg) produced a significant (p < 
0.001) and dose-dependent decrease in the number of writhes 
compared to control (Fig. 1). The inhibition rates of the number 
of writhing for the extract, at 50, 100 and 200 mg/kg, were 35, 
56.5 and 84.3%, respectively. The percentage inhibition of 
writhes by the extract at the dose of 200 mg/kg was higher 
than that of acetylsalicylic acid (44.1%). 
Tail immersion test
The antinociceptive activity of the extract and morphine in 
the tail immersion test are shown in Fig. 2. At all doses, the 
effect of the extract was more pronounced after 90 min. At 90 
min, the highest reaction time of 8.8 ± 0.9 s (34.4% inhibition) 
was observed at the dose of 200 mg/kg. Morphine (10 mg/kg) 
produced a significant anti-nociceptive effect at all observation 
times when compared to control, with a maximum increase in 
tail flick latency at 30 min (91.9%, inhibition), which declined 
with time.
Figure 1 – Effect of Alafia barteri on acetic acid-induced 
writhing in mice. Values are mean ± SEM (n = 6). ***p < 0.001 
compared to control (One-way analysis of variance followed 
by Tukey’s multiple comparison test).
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Tail clip test
The results obtained from the tail clip test are presented in 
Table 1. The extract exhibited a low and not dose-dependent 
analgesic effect against tail clip-induced algesic response in 
mice compared to control. The effect was only significant 
(p < 0.05) at the dose of 100 mg/kg (22.4% inhibition). Morphine 
(10 mg/kg) exhibited a significant (p < 0.01) analgesic activity 
(55.8% inhibition) in this test. 
Formalin test
In the control group the results showed an intensified 
nociceptive response in early and late phases of formalin 
test. The mean paw licking response times were 71.3 ± 
8.9 s and 91.8 ± 9.8 s respectively (Table 2).  The extract 
at all doses (50, 100 and 200 mg/kg, p.o.) significantly (p < 
0.05; p < 0.001) reduced the time spent by the mice licking 
the injected paws, both in the early and late phases when 
compared with controls. The effect in the late phase appears 
to be higher than the earlier phase. The inhibition rates of 
formalin-induced licking in the late phase compared with 
the control were 47.4, 55, and 83.5%, respectively. Morphine 
significantly inhibited pain (100%) over the control, both at 
early and late phases.
Anti-inflammatory studies
Carrageenan-induced oedema
As shown in Table 3, the extract at 50 and 100 mg/kg doses 
significantly (p < 0.001; p < 0.01; p < 0.05) inhibited the increase 
of paw oedema from 2 to 5 h. The maximum inhibitory effect of 
the extract was recorded at the 100 mg/kg dose  (78.85%) at 5 h. 
Oral administration of indomethacin (10 mg/kg) also reduced 
the oedema with significant inhibition of 44.44% and 46.15% , 
at 3 and 5 h, respectively.
Figure 2 – Effect of Alafia barteri on pain induced responses 
in tail immersion test. ap < 0.05, bp < 0.01, cp < 0.001 indicates 
significant difference when compare with control using Two-
way ANOVA followed by Bonferroni’s test.
Treatment
Dose 
(mg/kg)
Pre-treatment 
reaction latency (s)
Post-treatment
reaction latency (s)
% Inhibition
Control 10 ml/kg 4.3 ± 0.5 2.1 ± 0.2 -
A.  barteri 50 2.6 ± 0.5 5.8 ± 0.6 26.2
100 3.8 ± 0.6 6.3 ± 1.0a 22.4
200 4.2 ± 1.8 4.7 ± 0.3 4.5
Morphine 10 2.6 ± 0.6 9.5 ± 1.7b 55.8
Values are mean ± SEM, (n=6). ap < 0.05, bp < 0.001 compared to control (One-way analysis of variance followed by Tukey’s multiple comparison 
test).
Treatment
Dose 
(mg/kg)
Early phase
(0-5 min)
% 
Inhibition
Late phase
(15-30 min)
% 
Inhibition
Control 10 ml/kg 71.3 ± 8.9 - 91.8 ± 9.8 -
A.  barteri 50 43.6 ± 3.9a 38.9 48.3 ± 5.0b 47.4
100 46.7 ± 5.0c 34.5 41.3 ± 6.5b 55.0
200 24.7 ± 2.9b 65.4 15.2 ± 6.5b 83.5
Morphine 10 00.0   0.0b 100 00.0 ± 0.0b 100.0
Values are mean ± SEM, (n=6). ap < 0.01, bp < 0.001, cp < 0.05 compared to control (One-way analysis of variance followed by Tukey’s multiple 
comparison test).
Table 1
Effect of Alafia barteri on tail clip-induced pain in mice.
Table 2
Effect of Alafia barteri on formalin-induced pain in mice.
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Xylene-induced oedema
The oedema inhibitory value of the extract at the doses 
of 50, 100 and 200 mg/kg were 46.15, 53.85 and 78.85%, 
respectively (Fig. 3). A statistically significant peak effect 
(78.85% inhibition) was observed at the dose of 200 mg/kg, 
compared to control. Dexamethasone (1 mg/kg, p.o.) exhibited 
a significant inhibitory effect on xylene-induced ear oedema 
with inhibition value of 100%.
Discussion
The study investigated the antinociceptive and anti-
inflammatory effects of Alafia barteri Oliv., Apocynaceae 
leaves ethanolic extract. The antinociceptive activity was 
carried out in a broad panel of rodent models of acute 
pain; such as, the acetic acid-induced writhing, tail clip, 
tail immersion and formalin tests. These methods are 
classical nociception models used to screen prospective 
antinociceptive compounds or plant extracts.
Antinociceptive assessment using the acetic acid-
induced writhing test showed that oral administration of 
A. barteri produced a statistically significant inhibition 
of writhes compared to the control. This is an indication of the 
peripheral analgesic activity of the extract, since any agent 
that lowers the writhing number demonstrates analgesia by 
inhibiting prostaglandin synthesis, a peripheral mechanism 
of pain inhibition (Alam et al., 2009; Loganayaki et al., 2012). 
Although this method proves to have great sensitivity to 
central and peripheral analgesic drugs, the abdominal 
writhing response may be suppressed by muscle relaxants 
as well as other drugs, leaving scope for the misinterpretation 
of results (Le Bars et al., 2001).
The tail clip and tail immersion methods were used 
to evaluate the central mechanism of analgesic activity 
of the extract. The extract exhibited low activity in these 
two models of nociception. It is known that centrally 
acting analgesic drugs elevate the pain threshold of mice 
related to pressure and heat (Singh and Majumdar, 1995). 
The tail clip test is useful in elucidating centrally mediated 
antinociceptive responses, which focuses mainly on 
changes above the spinal cord level (Vongtau et al., 2004; 
Özkay and Can, 2013) while the tail immersion, a thermal- 
induced nociception, indicates narcotic involvement (Besra 
et al., 1996). Thermal nociceptive tests are more sensitive 
to opioid-μ receptors, and non-thermal tests are more 
sensitive to opioid-k receptors (Haider et al., 2012). The 
results obtained from these two models suggest that the 
antinociceptive activity of the extract may not significantly 
involve central mechanism of action.
Treatment
Dose 
(mg/kg)
Increase in paw circumference (cm)
1 h 2 h 3 h 4 h 5 h
Control (ml/kg) 10 0.3 ± 0.0 0.4 ± 0.0 0.45 ± 0.1 0.5 ± 0.1 0.5 ± 0.1
Extract 50
0.3 ± 0.0
(24.2)
0.3 ± 0.0
(21.1)
0.4 ± 0.0
(22.2)
0.3 ± 0.1a
(46.2)
0.2 ± 0.0b
(55.8)
100
0.1 ± 0.0b
(69.7)
0.2 ± 0.0c
(55.3)
0.2 ± 0.0b
(66.7)
0.1 ± 0.0b
(75.0)
0.1 ± 0.0b
(78.9)
200
0.3 ± 0.0
(24.2)
0.2 ± 0.1a
(39.5)
0.2 ± 0.2a
(48.9)
0.3 ± 0.0a
(40.4)
0.3 ± 0.0c
(46.2)
Indomethacin 10
0.3 ± 0.0
(15.2)
0.3 ± 0.0
(26.3)
0.3 ± 0.0a
(44.4)
0.3 ± 0.0
(36.5)
0.3 ± 0.0c
(46.2)
Values are mean ± SEM, (n=6). ap < 0.05, bp < 0.001, cp < 0.01 vs. control (One-way analysis of variance followed by Tukey’s multiple comparison 
test). Values in parenthesis are % inhibition.
Table 3
Effect of Alafia barteri on carrageenan-induced inflammation in rats.
Fig. 3 – Effect of Alafia barteri extract on xylene-induced 
mouse ear oedema test. Values are mean ± SEM, (n = 5).  
*p < 0.05 vs. control (One-way analysis of variance followed 
by Dunnett’s post test).
Polyphenol content
The total phenolic content expressed as gallic acid equivalents 
for A. barteri extract was 541.40 mg GAE/g, while the flavonoid 
and proanthocyanidin contents were 310.66 mg quercetin 
equivalent/g and 529.39 mg catechin equivalent/g of dried 
extract, respectively.
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In order to further evaluate and clarify the possible 
mechanism of the antinociceptive effect of the extract, the 
formalin test was carried out. In the formalin test, two distinct 
phases of intensive licking and biting activities have been 
identified. The early phase (first 5 min) is thought to be caused 
predominantly by C-fibre activation due to the peripheral 
stimulus caused by formalin. A second burst of licking 
behaviour occurs after 15 to 30 min and seems to be related 
to the inflammatory response elicited by formalin. This phase 
is termed inflammatory (Hunskaar and Hole, 1987; Milano et 
al., 2008). The extract demonstrated antinociceptive activity 
in blocking both phases of the formalin response. However, 
the effect of the extract was more pronounced in the late 
phase. Manifestation in the late phase is due to inflammation 
causing a release of serotonin, histamine, bradykinin and 
prostaglandins, which at least to some degree can cause the 
sensitization of the central nociceptive neurons (Verma et al., 
2005). It then implies that the antinociceptive activity of the 
extract possibly resulted from its peripheral action, which 
might also suggest an anti-inflammatory action. 
The in vivo anti-inflammatory activity of the extract 
was investigated using two common inflammatory animal 
models, i.e. carrageenan-induced paw oedema in rats, 
and xylene-induced ear oedema in mice. Carrageenan-
induced inflammation is useful in detecting orally active 
anti-inflammatory agents; therefore, it has a significant 
predictive value for anti-inflammatory agents acting through 
mediators of acute inflammation (Badole et al., 2012). The 
development of oedema induced by carrageenan injection 
produces a biphasic event. In the first phase, during the first 
hour, histamine, serotonin and bradykinin are the mediators 
involved, while prostaglandins are implicated in the second 
phase (3-5 h) (Marrassini et al., 2010). The extract exhibited a 
moderate inhibitory effect at the early phase but significantly 
inhibited the paw oedema in late phase of inflammation. The 
effect of the extract in this model may be attributed to the 
inhibition of the release of pro-inflammatory mediators of 
acute inflammation, especially prostaglandins.
Xylene can induce mouse ear oedema, which may involve 
inflammatory mediators such as histamine, kinin and 
fibrinolysin. These mediators can promote vasodilation 
and increase vascular permeability (Li et al., 2011). Xylene ear 
oedema model also allows the evaluation of anti-inflammatory 
steroids which inihibit phospholipase A2 (PLA2) enzymes 
(Ndebia et al., 2011). The ethanolic extract of A. barteri was 
able to reduce inflammation in this model. This finding 
suggests that the extract may interfere with the actions of 
inflammatory mediators and enzymes (PLA2) to produce the 
anti-inflammatory effect in this model. 
Phenols are the most wide spread secondary metabolite in 
plant kingdom. There is abundant literature regarding medicinal 
plants establishing relations between anti-inflammatory, 
analgesic and phenol/flavonoid content (Calixto et 
al., 2000; Deliorman et al., 2007; Saeed et al., 2010; Deng et al., 
2011). Although no record of chemical constituents isolated 
and characterized from this plant species was found, and 
the methods used for the identification of phytochemical 
constituents are preliminary in nature, it could be suggested 
that the antinociceptive and anti-inflammatory effects 
recorded for A. barteri in this study, may be caused by the total 
polyphenolic constituents present in the plant. 
In summary, comparing the results obtained in the 
antinociceptive activity models; the ethanolic extract of 
A. barteri was relatively potent in acetic acid writhing test, 
thus, indicating peripheral antinociception. Similarly, the 
highly significant inhibitory effect of the extract on 
the nociceptive response in the late phase of the formalin 
test suggests that the extract could suppress inflammatory 
nociception. Furthermore, in agreement with the results 
from the antinociceptive tests, the extract also elicited anti-
inflammatory effects. The results obtained in this study 
established the antinociceptive and anti-inflammatory 
actions for the extract. However, the mechanism of 
these actions is uncertain, and the active chemical compounds 
responsible of the antinociceptive and anti-inflammatory 
activities of the extract remains to be elucidated. 
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